Study to Investigate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of Single & Repeat Doses of GSK2269557
Clinical trial NCT01462617 · COMPLETED
Trial details
- NCT number
- NCT01462617
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-24
- Primary completion
- 2012-03-26
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.